UNH Analyst Ratings

Deutsche Bank downgraded UnitedHealth to Hold in late October after the stock's sharp decline. Goldman initiated at Buy ($406) earlier that month. Consensus is Buy at $137 average target — the setup is contrarian with margin recovery expected in 2026.

ANALYST RATINGS
Hold$313
UNH
Hold$333
Downgrade
2025-10-29
Buy$406
Initiated
2025-10-14
Underperform$198
Downgrade
2025-07-31
Outperform$325
Reiterated
2025-07-30
Neutral$312
Downgrade
2025-06-11
Downgrade
2025-10-29
Deutsche Bank
RatingHold
FromBuy
Target$333
From—
Initiated
2025-10-14
Goldman
RatingBuy
From—
Target$406
From—
Downgrade
2025-07-31
Robert W. Baird
RatingUnderperform
FromNeutral
Target$198
From—
Reiterated
2025-07-30
Oppenheimer
RatingOutperform
From—
Target$325
From$400
Downgrade
2025-06-11
Robert W. Baird
RatingNeutral
FromOutperform
Target$312
From—
Downgrade
2025-05-21
HSBC Securities
RatingReduce
FromHold
Target$270
From—
Downgrade
2025-05-19
TD Cowen
RatingHold
FromBuy
Target$308
From—
Downgrade
2025-05-14
BofA Securities
RatingNeutral
FromBuy
Target$350
From—
Downgrade
2025-04-22
HSBC Securities
RatingHold
FromBuy
Target$490
From—
Upgrade
2025-01-10
HSBC Securities
RatingBuy
FromHold
Target$595
From—
Reiterated
2025-01-06
Truist
RatingBuy
From—
Target$610
From$625
Initiated
2024-10-11
KeyBanc Capital Markets
RatingOverweight
From—
Target$675
From—
Upgrade
2024-07-17
Jefferies
RatingBuy
FromHold
Target$647
From$481
Reiterated
2024-07-17
RBC Capital Mkts
RatingOutperform
From—
Target$615
From$555
Upgrade
2024-06-05
HSBC Securities
RatingBuy
FromHold
Target$580
From—
Initiated
2024-05-30
Robert W. Baird
RatingOutperform
From—
Target$597
From—
Upgrade
2024-04-04
HSBC Securities
RatingHold
FromReduce
Target$460
From—